{
  "regimen_catalog": [
    {
      "id": "cisplatin-pemetrexed",
      "name": "Cisplatin + Pemetrexed",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Pemetrexed"
      ]
    },
    {
      "id": "carboplatin-pemetrexed",
      "name": "Carboplatin + Pemetrexed",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Pemetrexed"
      ]
    },
    {
      "id": "cisplatin-gemcitabine",
      "name": "Cisplatin + Gemcitabin",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Gemcitabin"
      ]
    },
    {
      "id": "carboplatin-gemcitabine",
      "name": "Carboplatin + Gemcitabin",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Gemcitabin"
      ]
    },
    {
      "id": "carboplatin-paclitaxel",
      "name": "Carboplatin + Paclitaxel",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Paclitaxel"
      ]
    },
    {
      "id": "carboplatin-nab-paclitaxel",
      "name": "Carboplatin + Nab-Paclitaxel",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Nab-Paclitaxel"
      ]
    },
    {
      "id": "cisplatin-docetaxel",
      "name": "Cisplatin + Docetaxel",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Docetaxel"
      ]
    },
    {
      "id": "cisplatin-vinorelbine",
      "name": "Cisplatin + Vinorelbin",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Vinorelbin"
      ]
    },
    {
      "id": "carboplatin-vinorelbine",
      "name": "Carboplatin + Vinorelbin",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Vinorelbin"
      ]
    },
    {
      "id": "cisplatin-etoposide",
      "name": "Cisplatin + Etoposid",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Etoposid"
      ]
    },
    {
      "id": "carboplatin-etoposide",
      "name": "Carboplatin + Etoposid",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Etoposid"
      ]
    },
    {
      "id": "pembrolizumab-carbo-pemetrexed",
      "name": "Pembrolizumab + Carboplatin + Pemetrexed",
      "group": "Chemotherapie",
      "aliases": [
        "Pembrolizumab + Carboplatin + Pemetrexed"
      ]
    },
    {
      "id": "pembrolizumab-carbo-paclitaxel",
      "name": "Pembrolizumab + Carboplatin + (nab)Paclitaxel",
      "group": "Chemotherapie",
      "aliases": [
        "Pembrolizumab + Carboplatin + (nab)Paclitaxel"
      ]
    },
    {
      "id": "atezolizumab-carbo-nab-pac",
      "name": "Atezolizumab + Carboplatin + Nab-Paclitaxel",
      "group": "Chemotherapie",
      "aliases": [
        "Atezolizumab + Carboplatin + Nab-Paclitaxel"
      ]
    },
    {
      "id": "atezolizumab-bev-carbo-pac",
      "name": "Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel",
      "group": "Chemotherapie",
      "aliases": [
        "Atezolizumab + Bevacizumab + Carboplatin + Paclitaxel"
      ]
    },
    {
      "id": "durvalumab-carbo-etoposide",
      "name": "Durvalumab + Carboplatin + Etoposid (Ext. SCLC)",
      "group": "Chemotherapie",
      "aliases": [
        "Durvalumab + Carboplatin + Etoposid (Ext. SCLC)"
      ]
    },
    {
      "id": "atezolizumab-carbo-etoposide",
      "name": "Atezolizumab + Carboplatin + Etoposid (Ext. SCLC)",
      "group": "Chemotherapie",
      "aliases": [
        "Atezolizumab + Carboplatin + Etoposid (Ext. SCLC)"
      ]
    },
    {
      "id": "cisplatin-pemetrexed-bev",
      "name": "Cisplatin + Pemetrexed + Bevacizumab (Mesotheliom)",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Pemetrexed + Bevacizumab (Mesotheliom)"
      ]
    },
    {
      "id": "nivolumab-ipilimumab",
      "name": "Nivolumab + Ipilimumab (Kombinations-Immuntherapie)",
      "group": "Immuntherapie",
      "aliases": [
        "Nivolumab + Ipilimumab (Kombinations-Immuntherapie)"
      ]
    },
    {
      "id": "nivolumab-ipi-chemo",
      "name": "Nivolumab + Ipilimumab + 2× Chemotherapie (z.B. CheckMate 9LA)",
      "group": "Chemotherapie",
      "aliases": [
        "Nivolumab + Ipilimumab + 2× Chemotherapie (z.B. CheckMate 9LA)"
      ]
    },
    {
      "id": "durvalumab-tremelimumab-chemo",
      "name": "Durvalumab + Tremelimumab + Chemotherapie (z.B. POSEIDON)",
      "group": "Chemotherapie",
      "aliases": [
        "Durvalumab + Tremelimumab + Chemotherapie (z.B. POSEIDON)"
      ]
    },
    {
      "id": "durvalumab-consolidation",
      "name": "Durvalumab (Konsolidierung nach Radiochemo, Stadium III NSCLC)",
      "group": "Immuntherapie",
      "aliases": [
        "Durvalumab (Konsolidierung nach Radiochemo, Stadium III NSCLC)"
      ]
    },
    {
      "id": "pemetrexed-monotherapy",
      "name": "Pemetrexed (Monotherapie)",
      "group": "Chemotherapie",
      "aliases": [
        "Pemetrexed (Monotherapie)"
      ]
    },
    {
      "id": "docetaxel-monotherapy",
      "name": "Docetaxel (Monotherapie)",
      "group": "Chemotherapie",
      "aliases": [
        "Docetaxel (Monotherapie)"
      ]
    },
    {
      "id": "gemcitabine-monotherapy",
      "name": "Gemcitabin (Monotherapie)",
      "group": "Chemotherapie",
      "aliases": [
        "Gemcitabin (Monotherapie)"
      ]
    },
    {
      "id": "vinorelbine-monotherapy",
      "name": "Vinorelbin (Monotherapie)",
      "group": "Chemotherapie",
      "aliases": [
        "Vinorelbin (Monotherapie)"
      ]
    },
    {
      "id": "cisplatin-doxorubicin-cyclophosphamide",
      "name": "Cisplatin + Doxorubicin + Cyclophosphamid (CAP)",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Doxorubicin + Cyclophosphamid (CAP)"
      ]
    },
    {
      "id": "carboplatin-paclitaxel-thymus",
      "name": "Carboplatin + Paclitaxel (Thymus-Ca Erstlinie)",
      "group": "Chemotherapie",
      "aliases": [
        "Carboplatin + Paclitaxel (Thymus-Ca Erstlinie)"
      ]
    },
    {
      "id": "cisplatin-ifosfamide-etoposide",
      "name": "Cisplatin + Ifosfamid + Etoposid (VIP-Schema)",
      "group": "Chemotherapie",
      "aliases": [
        "Cisplatin + Ifosfamid + Etoposid (VIP-Schema)"
      ]
    },
    {
      "id": "octreotide-lanreotide",
      "name": "Octreotid/Lanreotid (Somatostatin-Analogon)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Octreotid/Lanreotid (Somatostatin-Analogon)"
      ]
    },
    {
      "id": "everolimus",
      "name": "Everolimus (mTOR-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Everolimus (mTOR-Inhibitor)"
      ]
    },
    {
      "id": "capecitabine-temozolomide",
      "name": "Capecitabin + Temozolomid (CAPTEM)",
      "group": "Chemotherapie",
      "aliases": [
        "Capecitabin + Temozolomid (CAPTEM)"
      ]
    },
    {
      "id": "osimertinib",
      "name": "Osimertinib (EGFR-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Osimertinib (EGFR-TKI)"
      ]
    },
    {
      "id": "gefitinib",
      "name": "Gefitinib (EGFR-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Gefitinib (EGFR-TKI)"
      ]
    },
    {
      "id": "erlotinib",
      "name": "Erlotinib (EGFR-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Erlotinib (EGFR-TKI)"
      ]
    },
    {
      "id": "afatinib",
      "name": "Afatinib (EGFR-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Afatinib (EGFR-TKI)"
      ]
    },
    {
      "id": "alectinib",
      "name": "Alectinib (ALK-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Alectinib (ALK-TKI)"
      ]
    },
    {
      "id": "crizotinib",
      "name": "Crizotinib (ALK/ROS1-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Crizotinib (ALK/ROS1-TKI)"
      ]
    },
    {
      "id": "brigatinib",
      "name": "Brigatinib (ALK-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Brigatinib (ALK-TKI)"
      ]
    },
    {
      "id": "lorlatinib",
      "name": "Lorlatinib (ALK-TKI)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Lorlatinib (ALK-TKI)"
      ]
    },
    {
      "id": "entrectinib",
      "name": "Entrectinib (ROS1/NTRK-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Entrectinib (ROS1/NTRK-Inhibitor)"
      ]
    },
    {
      "id": "selpercatinib",
      "name": "Selpercatinib (RET-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Selpercatinib (RET-Inhibitor)"
      ]
    },
    {
      "id": "pralsetinib",
      "name": "Pralsetinib (RET-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Pralsetinib (RET-Inhibitor)"
      ]
    },
    {
      "id": "capmatinib",
      "name": "Capmatinib (MET-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Capmatinib (MET-Inhibitor)"
      ]
    },
    {
      "id": "tepotinib",
      "name": "Tepotinib (MET-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Tepotinib (MET-Inhibitor)"
      ]
    },
    {
      "id": "sotorasib",
      "name": "Sotorasib (KRAS^G12C^-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Sotorasib (KRAS^G12C^-Inhibitor)"
      ]
    },
    {
      "id": "adagrasib",
      "name": "Adagrasib (KRAS^G12C^-Inhibitor)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Adagrasib (KRAS^G12C^-Inhibitor)"
      ]
    },
    {
      "id": "amivantamab",
      "name": "Amivantamab (EGFR-Exon20-Antikörper)",
      "group": "Zielgerichtete Therapie",
      "aliases": [
        "Amivantamab (EGFR-Exon20-Antikörper)"
      ]
    },
    {
      "id": "nivolumab",
      "name": "Nivolumab (PD-1-Inhibitor)",
      "group": "Immuntherapie",
      "aliases": [
        "Nivolumab (PD-1-Inhibitor)"
      ]
    },
    {
      "id": "pembrolizumab",
      "name": "Pembrolizumab (PD-1-Inhibitor)",
      "group": "Immuntherapie",
      "aliases": [
        "Pembrolizumab (PD-1-Inhibitor)"
      ]
    },
    {
      "id": "atezolizumab",
      "name": "Atezolizumab (PD-L1-Inhibitor)",
      "group": "Immuntherapie",
      "aliases": [
        "Atezolizumab (PD-L1-Inhibitor)"
      ]
    },
    {
      "id": "durvalumab",
      "name": "Durvalumab (PD-L1-Inhibitor)",
      "group": "Immuntherapie",
      "aliases": [
        "Durvalumab (PD-L1-Inhibitor)"
      ]
    },
    {
      "id": "ipilimumab",
      "name": "Ipilimumab (CTLA-4-Inhibitor)",
      "group": "Immuntherapie",
      "aliases": [
        "Ipilimumab (CTLA-4-Inhibitor)"
      ]
    },
    {
      "id": "topotecan",
      "name": "Topotecan (2nd Line SCLC)",
      "group": "Chemotherapie",
      "aliases": [
        "Topotecan (2nd Line SCLC)"
      ]
    },
    {
      "id": "lurbinectedin",
      "name": "Lurbinectedin (2nd Line SCLC)",
      "group": "Chemotherapie",
      "aliases": [
        "Lurbinectedin (2nd Line SCLC)"
      ]
    },
    {
      "id": "cav",
      "name": "CAV-Regime (Cyclophosphamid + Adriamycin + Vincristin)",
      "group": "Chemotherapie",
      "aliases": [
        "CAV-Regime (Cyclophosphamid + Adriamycin + Vincristin)"
      ]
    }
  ],
  "items": [
    {
      "id": "sup-001",
      "name": "Ondansetron 8 mg",
      "substance": "Ondansetron",
      "class": "Antiemetikum (5-HT3)",
      "indication": "Übelkeit/Erbrechen unter Chemo vorbeugen",
      "dosing": "8 mg p.o. 1–2×/Tag, 30–60 min vor Chemo",
      "max_daily": "16 mg/Tag",
      "side_effects": "Kopfschmerzen, Verstopfung, selten Herzrhythmus",
      "warnings": "Bei anhaltendem Erbrechen oder Herzrasen Arzt kontaktieren",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; SCLC",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "cisplatin-gemcitabine",
        "carboplatin-gemcitabine",
        "carboplatin-paclitaxel",
        "carboplatin-nab-paclitaxel",
        "cisplatin-docetaxel",
        "cisplatin-vinorelbine",
        "carboplatin-vinorelbine",
        "cisplatin-etoposide",
        "carboplatin-etoposide",
        "pembrolizumab-carbo-pemetrexed",
        "pembrolizumab-carbo-paclitaxel",
        "atezolizumab-carbo-nab-pac",
        "atezolizumab-bev-carbo-pac",
        "durvalumab-carbo-etoposide",
        "atezolizumab-carbo-etoposide",
        "cisplatin-pemetrexed-bev",
        "docetaxel-monotherapy",
        "gemcitabine-monotherapy",
        "vinorelbine-monotherapy",
        "cisplatin-doxorubicin-cyclophosphamide",
        "carboplatin-paclitaxel-thymus",
        "cisplatin-ifosfamide-etoposide",
        "capecitabine-temozolomide",
        "cav"
      ]
    },
    {
      "id": "sup-grani",
      "name": "Granisetron 2 mg",
      "substance": "Granisetron",
      "class": "Antiemetikum (5-HT3)",
      "indication": "Antiemese am Chemotag",
      "dosing": "1–2 mg p.o. am Chemotag",
      "max_daily": "2 mg/Tag",
      "side_effects": "Kopfschmerz, Verstopfung",
      "warnings": "Bei schwerer Verstopfung Arzt kontaktieren",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; SCLC",
      "regimens": []
    },
    {
      "id": "sup-004",
      "name": "Palonosetron 0,25 mg",
      "substance": "Palonosetron",
      "class": "Antiemetikum (5-HT3)",
      "indication": "Lang wirksame Antiemese (bis 3 Tage)",
      "dosing": "0,25 mg i.v. ca. 30 min vor Chemo",
      "max_daily": "0,25 mg/Tag",
      "side_effects": "Kopfschmerz, Verstopfung",
      "warnings": "Bei Obstipation abklären",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; SCLC",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "cisplatin-gemcitabine",
        "carboplatin-gemcitabine",
        "carboplatin-paclitaxel",
        "carboplatin-nab-paclitaxel",
        "cisplatin-docetaxel",
        "cisplatin-vinorelbine",
        "carboplatin-vinorelbine",
        "cisplatin-etoposide",
        "carboplatin-etoposide",
        "pembrolizumab-carbo-pemetrexed",
        "pembrolizumab-carbo-paclitaxel",
        "atezolizumab-carbo-nab-pac",
        "atezolizumab-bev-carbo-pac",
        "durvalumab-carbo-etoposide",
        "atezolizumab-carbo-etoposide",
        "cisplatin-pemetrexed-bev",
        "cisplatin-doxorubicin-cyclophosphamide",
        "carboplatin-paclitaxel-thymus",
        "cisplatin-ifosfamide-etoposide",
        "cav"
      ]
    },
    {
      "id": "sup-003",
      "name": "Aprepitant",
      "substance": "Aprepitant",
      "class": "Antiemetikum (NK1)",
      "indication": "Verzögertes Erbrechen (v.a. Cisplatin)",
      "dosing": "Tag1: 125 mg; Tag2–3: 80 mg p.o.",
      "max_daily": "125 mg (Tag1)",
      "side_effects": "Müdigkeit, Aufstoßen",
      "warnings": "Interaktionen mit Cortison beachten",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; SCLC",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "cisplatin-gemcitabine",
        "carboplatin-gemcitabine",
        "carboplatin-paclitaxel",
        "carboplatin-nab-paclitaxel",
        "cisplatin-docetaxel",
        "cisplatin-vinorelbine",
        "carboplatin-vinorelbine",
        "cisplatin-etoposide",
        "carboplatin-etoposide",
        "pembrolizumab-carbo-pemetrexed",
        "pembrolizumab-carbo-paclitaxel",
        "atezolizumab-carbo-nab-pac",
        "atezolizumab-bev-carbo-pac",
        "durvalumab-carbo-etoposide",
        "atezolizumab-carbo-etoposide",
        "cisplatin-pemetrexed-bev",
        "cisplatin-doxorubicin-cyclophosphamide",
        "carboplatin-paclitaxel-thymus",
        "cisplatin-ifosfamide-etoposide",
        "cav"
      ]
    },
    {
      "id": "sup-002",
      "name": "Dexamethason",
      "substance": "Dexamethason",
      "class": "Glukokortikoid",
      "indication": "Teil der Antiemese / Prämedikation",
      "dosing": "4–8 mg p.o./i.v. an Chemo-Tagen",
      "max_daily": "16 mg/Tag",
      "side_effects": "Schlafstörungen, Blutzuckeranstieg",
      "warnings": "Bei Diabetes Blutzucker engmaschig kontrollieren",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "cisplatin-gemcitabine",
        "carboplatin-gemcitabine",
        "carboplatin-paclitaxel",
        "carboplatin-nab-paclitaxel",
        "cisplatin-docetaxel",
        "cisplatin-vinorelbine",
        "carboplatin-vinorelbine",
        "cisplatin-etoposide",
        "carboplatin-etoposide",
        "pembrolizumab-carbo-pemetrexed",
        "pembrolizumab-carbo-paclitaxel",
        "atezolizumab-carbo-nab-pac",
        "atezolizumab-bev-carbo-pac",
        "durvalumab-carbo-etoposide",
        "atezolizumab-carbo-etoposide",
        "cisplatin-pemetrexed-bev",
        "pemetrexed-monotherapy",
        "docetaxel-monotherapy",
        "gemcitabine-monotherapy",
        "vinorelbine-monotherapy",
        "cisplatin-doxorubicin-cyclophosphamide",
        "carboplatin-paclitaxel-thymus",
        "cisplatin-ifosfamide-etoposide",
        "capecitabine-temozolomide",
        "amivantamab",
        "cav"
      ]
    },
    {
      "id": "sup-mcp",
      "name": "Metoclopramid 10 mg",
      "substance": "Metoclopramid",
      "class": "Antiemetikum (D2)",
      "indication": "Durchbruchübelkeit",
      "dosing": "10 mg p.o. bis 3×/Tag bei Bedarf",
      "max_daily": "30 mg/Tag",
      "side_effects": "Müdigkeit, selten Muskelzuckungen",
      "warnings": "Bei Zuckungen sofort absetzen und Arzt kontaktieren",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-005",
      "name": "Olanzapin 5–10 mg",
      "substance": "Olanzapin",
      "class": "Antiemetikum (Neuroleptikum)",
      "indication": "Refraktäre Übelkeit",
      "dosing": "5–10 mg p.o. abends für 3–4 Tage",
      "max_daily": "10 mg/Tag",
      "side_effects": "Müdigkeit, Schwindel",
      "warnings": "Nach Einnahme nicht Auto fahren",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "cisplatin-gemcitabine",
        "carboplatin-gemcitabine",
        "carboplatin-paclitaxel",
        "carboplatin-nab-paclitaxel",
        "cisplatin-docetaxel",
        "cisplatin-vinorelbine",
        "carboplatin-vinorelbine",
        "cisplatin-etoposide",
        "carboplatin-etoposide",
        "pembrolizumab-carbo-pemetrexed",
        "pembrolizumab-carbo-paclitaxel",
        "atezolizumab-carbo-nab-pac",
        "atezolizumab-bev-carbo-pac",
        "durvalumab-carbo-etoposide",
        "atezolizumab-carbo-etoposide",
        "cisplatin-pemetrexed-bev",
        "cisplatin-doxorubicin-cyclophosphamide",
        "carboplatin-paclitaxel-thymus",
        "cisplatin-ifosfamide-etoposide",
        "cav"
      ]
    },
    {
      "id": "sup-clem",
      "name": "Clemastin 2 mg i.v.",
      "substance": "Clemastin",
      "class": "H1-Antihistaminikum",
      "indication": "Allergieprophylaxe (z.B. Paclitaxel)",
      "dosing": "2 mg i.v. ca. 30 min vor Chemo",
      "max_daily": "2 mg/Tag",
      "side_effects": "Müdigkeit, Mundtrockenheit",
      "warnings": "Nach Gabe nicht selbst Auto fahren",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-famo",
      "name": "Famotidin 20 mg i.v.",
      "substance": "Famotidin",
      "class": "H2-Blocker",
      "indication": "Teil der Paclitaxel-Prämedikation",
      "dosing": "20 mg i.v. vor Chemo",
      "max_daily": "20 mg/Tag",
      "side_effects": "Kopfschmerz, Schwindel",
      "warnings": "Bei Schwindel vorsichtig sein",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-007",
      "name": "Mesna",
      "substance": "Mesna",
      "class": "Uroprotektor",
      "indication": "Schutz vor Ifosfamid-Zystitis",
      "dosing": "i.v./p.o. verteilt – nach Ifos-Dosis",
      "max_daily": "schemaabhängig",
      "side_effects": "Übelkeit, Geruch/Geschmack",
      "warnings": "Viel trinken, Harndrang beachten",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "Thymustumoren",
      "regimens": [
        "cisplatin-doxorubicin-cyclophosphamide",
        "cisplatin-ifosfamide-etoposide"
      ]
    },
    {
      "id": "sup-atrop",
      "name": "Atropin 0,25–0,5 mg s.c.",
      "substance": "Atropin",
      "class": "Anticholinergikum",
      "indication": "Irinotecan-bedingtes cholinerges Syndrom",
      "dosing": "0,25–0,5 mg s.c. vor Gabe oder bei Symptomen",
      "max_daily": "0,5 mg/Tag",
      "side_effects": "Mundtrockenheit, Herzrasen",
      "warnings": "Bei Sehstörungen/Herzrasen Arzt",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC",
      "regimens": []
    },
    {
      "id": "sup-lop",
      "name": "Loperamid 2 mg",
      "substance": "Loperamid",
      "class": "Antidiarrhoikum",
      "indication": "Durchfälle unter Chemo/TKI",
      "dosing": "4 mg, dann 2 mg nach jedem ungeformten Stuhl",
      "max_daily": "16 mg/Tag",
      "side_effects": "Verstopfung, Bauchkrämpfe",
      "warnings": "Bei Fieber oder Blut im Stuhl sofort Arzt",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-doxy",
      "name": "Doxycyclin 100 mg",
      "substance": "Doxycyclin",
      "class": "Antibiotikum",
      "indication": "Prophylaxe EGFR-TKI-Hautausschlag",
      "dosing": "100 mg p.o. 2×/Tag für ~6 Wochen",
      "max_daily": "200 mg/Tag",
      "side_effects": "Sonnenempfindlichkeit, Übelkeit",
      "warnings": "Sonnenschutz; nicht nüchtern einnehmen",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC (EGFR)",
      "regimens": []
    },
    {
      "id": "sup-panto",
      "name": "Pantoprazol 40 mg",
      "substance": "Pantoprazol",
      "class": "PPI",
      "indication": "Magenschutz (z.B. unter Steroiden)",
      "dosing": "40 mg p.o. 1×/Tag",
      "max_daily": "40 mg/Tag",
      "side_effects": "Durchfall, Kopfschmerzen",
      "warnings": "Nur so lange wie nötig einnehmen",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-009",
      "name": "Vitamin B12 1000 µg i.m.",
      "substance": "Cyanocobalamin",
      "class": "Vitamin",
      "indication": "Pemetrexed-Begleitmedikation",
      "dosing": "1000 µg i.m. alle ~9 Wochen",
      "max_daily": "1000 µg i.m.",
      "side_effects": "Einstichschmerz",
      "warnings": "Selten Allergie",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; Mesotheliom",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "pembrolizumab-carbo-pemetrexed",
        "cisplatin-pemetrexed-bev",
        "pemetrexed-monotherapy"
      ]
    },
    {
      "id": "sup-008",
      "name": "Folsäure 1 mg",
      "substance": "Folsäure",
      "class": "Vitamin",
      "indication": "Pemetrexed-Begleitmedikation",
      "dosing": "1 mg p.o. täglich",
      "max_daily": "1 mg/Tag",
      "side_effects": "i.d.R. keine",
      "warnings": "Nicht überdosieren",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; Mesotheliom",
      "regimens": [
        "cisplatin-pemetrexed",
        "carboplatin-pemetrexed",
        "pembrolizumab-carbo-pemetrexed",
        "cisplatin-pemetrexed-bev",
        "pemetrexed-monotherapy"
      ]
    },
    {
      "id": "sup-pegfil",
      "name": "Pegfilgrastim 6 mg",
      "substance": "Pegfilgrastim",
      "class": "G-CSF",
      "indication": "Prophylaxe febrile Neutropenie",
      "dosing": "6 mg s.c. ≥24 h nach Chemo",
      "max_daily": "6 mg/Applikation",
      "side_effects": "Knochenschmerzen, Fieber",
      "warnings": "Bei linken Oberbauchschmerzen Arzt",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-epo",
      "name": "Epoetin alfa 40.000 IE",
      "substance": "Epoetin alfa",
      "class": "Erythropoetin",
      "indication": "Anämie unter Chemo (palliativ)",
      "dosing": "40.000 IE s.c. 1×/Woche",
      "max_daily": "40.000 IE",
      "side_effects": "Bluthochdruck, Thrombosen",
      "warnings": "Hb nicht >12 g/dl anheben",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "Alle",
      "regimens": []
    },
    {
      "id": "sup-deno",
      "name": "Denosumab 120 mg",
      "substance": "Denosumab",
      "class": "RANKL-Inhibitor",
      "indication": "Vorbeugung von Knochenkomplikationen",
      "dosing": "120 mg s.c. alle 4 Wochen",
      "max_daily": "120 mg",
      "side_effects": "Hypokalzämie, Knochenschmerzen",
      "warnings": "Calcium/Vitamin D; Zahnstatus prüfen",
      "regimen_category": "Sonstige",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; SCLC",
      "regimens": []
    },
    {
      "id": "sup-006",
      "name": "Diphenhydramin 50mg",
      "substance": "Diphenhydramin",
      "class": "H1-Antihistaminikum",
      "indication": "Allergieprophylaxe (z.B. Paclitaxel)",
      "dosing": "50mg alle 8 Stunden",
      "max_daily": "150mg",
      "side_effects": "Müdigkeit",
      "warnings": "nan",
      "regimen_category": "Chemotherapie",
      "specialty": "Thoraxonkologie",
      "disease": "NSCLC; SCLC",
      "regimens": [
        "carboplatin-paclitaxel",
        "pembrolizumab-carbo-paclitaxel",
        "atezolizumab-bev-carbo-pac",
        "carboplatin-paclitaxel-thymus",
        "amivantamab"
      ]
    },
    {
      "id": "sup010",
      "name": "Minocyclin 100mg",
      "substance": "Minocyclin",
      "class": "Antibiotikum (Tetracyclin)",
      "indication": "Prophylaxe eines hautbedingten Ausschlags unter EGFR-Inhibitoren (zielgerichtete Therapie)",
      "dosing": "nan",
      "max_daily": "nan",
      "side_effects": "nan",
      "warnings": "nan",
      "regimen_category": "nan",
      "specialty": "nan",
      "disease": "nan",
      "regimens": []
    }
  ]
}